Shionogi & Co., Ltd. Thursday announced it will implement a corporate reorganization and several personnel reassignments, effective December 1, 2025, in line with the upcoming absorption-type merger of Japan Tobacco Inc.'s pharmaceutical business.
As part of the reorganization, Shionogi will establish the Central Pharmaceutical Research Institute and the Development Business Division under its R&D Supervisory Unit. The Venture Alliance Management Office, under the same uni,t will also be renamed the Alliance Management Office.
In connection with the changes, Makoto Kakutani has been appointed Senior Vice President of the Central Pharmaceutical Research Institute, while Takayuki Yamaguchi will serve as Senior Vice President of the Development Business Division.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.